市场调查报告书
商品编码
1401210
脉搏血氧计全球市场规模、占有率、产业趋势分析报告:2023-2030 年按最终用户、类型和地区分類的展望和预测Global Pulse Oximeter Market Size, Share & Industry Trends Analysis Report By End User (Hospitals & Clinics, Homecare and Others), By Type (Fingertip, Handheld, Wrist worn, Bedside, and Others), By Regional Outlook and Forecast, 2023 - 2030 |
预计到 2030 年,全球脉搏血氧计市场规模将达到 34 亿美元,预测期内复合年增长率为 6.3%。 2022年市场规模为1404.36万辆,成长18.0%(2019-2022年)。
此外,疫情导致对脉搏血氧计的需求激增,特别是在早期阶段,呼吸道症状是 COVID-19 患者主要关注的问题。个人和医疗机构寻求这些设备来监测家庭和临床环境中的氧气水平。很大一部分 COVID-19 患者有中度症状或无症状,促使家庭监测广泛普及。脉搏血氧计对于患者自我监测和医疗保健专业人员远端追踪患者的氧气水平都至关重要。不断增长的需求刺激了市场的创新和产品开拓。医疗保健製造商探索了新功能和技术,以满足医疗保健专业人员和消费者不断变化的需求。因此,COVID-19的爆发对市场产生了正面的影响。
然而,在以较高的医疗基础设施和意识为特征的新兴市场中,对特定医疗设备的需求往往达到饱和状态。在这样的成熟市场中,很大一部分目标人口可能已经拥有或能够使用脉搏血氧计,这限制了市场扩张的新机会。在已开发地区,脉搏血氧仪普及广泛,普及较高。大多数人,包括医疗机构和个人,可能已经拥有这些设备,从而降低了额外销售的可能性。例如,将呼吸健康监测扩展到运动和健身应用,或将脉搏血氧仪整合到穿戴式装置中可以吸引新的使用者群体。这些方面可能会限制市场的成长。
最终用户前景
根据最终用户,市场分为医院/诊所、居家照护等。 2022年,居家照护领域在市场中获得了可观的收益占有率。患者便利性、经济效率以及在熟悉的环境中管理慢性病的能力等因素正在推动在家中提供医疗保健的运动。脉搏血氧计提供了一种实用且非侵入性的方法来监测家庭中的氧气水平。世界人口高龄化正在增加慢性呼吸道疾病和各种其他健康併发症的发生率。尤其是老年人,可能会受益于在家中监测血氧饱和度,脉搏血氧仪在这一人群中的采用率正在增加。因此,该细分市场预计将在未来几年内迅速扩张。
类型展望
依类型划分,市场可分为手持式、指尖式、腕戴式、床边式等。 2022年,指尖细分市场占据了市场最大的收益占有率。远端患者监护的普及,尤其是在大流行期间,促进了指尖脉搏血氧计的普及。患者可以在家中轻鬆使用这些设备,并将资料传输给医疗保健提供者,从而实现远端监控和介入。从这个角度来看,该细分市场的需求预计将会增加。
区域展望
从区域来看,市场分为北美、欧洲、亚太地区、拉丁美洲、中东和非洲。 2022 年,北美市场的收益占有率最高。北美,尤其美国,是世界上医疗保健支出最高的地区之一。成熟的医疗基础设施和对医疗技术的大量投资正在促进脉搏血氧计等先进医疗设备的采用。这些方面可能为该行业提供良好的成长前景。
The Global Pulse Oximeter Market size is expected to reach $3.4 billion by 2030, rising at a market growth of 6.3% CAGR during the forecast period. In the year 2022, the market attained a volume of 14,043.6 thousand units, experiencing a growth of 18.0% (2019-2022).
Pulse oximeters offer a user-friendly tool for patients to monitor their oxygen levels at home, fostering a sense of control and early intervention. Therefore, the Homecare segment acquired $690.8 million in 2022. Pulse oximeters provide a non-invasive and immediate way to measure oxygen saturation levels, enabling patients and healthcare professionals to monitor respiratory health regularly. Patients are increasingly becoming proactive in managing their health, and awareness campaigns have empowered individuals to take charge of their respiratory well-being. Some of the factors impacting the market are increasing remote patient monitoring, rising aging population around the world, and increasing saturation in various nations.
Home healthcare allows individuals, especially those with chronic conditions, to monitor their health without frequent visits to healthcare facilities. Pulse oximeters offer a convenient and accessible way for individuals to track their oxygen levels in the comfort of their homes. Patients with chronic respiratory conditions, such as COPD and asthma, often require continuous monitoring of their oxygen saturation levels. Home use of pulse oximeters facilitates regular monitoring, enabling individuals and their healthcare providers to manage chronic conditions more effectively. Additionally, respiratory conditions, such as chronic obstructive pulmonary disease (COPD), pneumonia, and other lung diseases, become more prevalent with age. The aging process can affect lung function, making older individuals more susceptible to respiratory challenges. Aging individuals may not always exhibit obvious symptoms of respiratory problems until the conditions have progressed. Pulse oximeters provide a non-invasive and quick way to assess oxygen saturation levels, enabling early detection of potential respiratory issues before they become severe. Pulse oximeters support this preference by offering a tool for home monitoring. Seniors can regularly check their oxygen levels, promoting independence and proactive health management. These factors will drive the demand for pulse oximeters in the coming years.
Further, the pandemic led to a surge in demand for pulse oximeters, especially during the early stages when respiratory symptoms were a primary concern for COVID-19 patients. Individuals and healthcare facilities sought these devices to monitor oxygen levels at home and clinical settings. A considerable proportion of COVID-19 patients exhibited moderate symptoms or were asymptomatic, which contributed to the increasing prevalence of home monitoring. Pulse oximeters became essential for patients to self-monitor and for healthcare professionals to track patients' oxygen levels remotely. The increased demand prompted innovation and product development in the market. Manufacturers explored new features and technologies to meet the evolving needs of healthcare professionals and consumers. Therefore, the COVID-19 pandemic positively impacted the market.
However, developed markets, characterized by high healthcare infrastructure and awareness, often reach a saturation point for certain medical devices. In these mature markets, a large proportion of the target population may already own or have access to pulse oximeters, limiting new opportunities for market expansion. The widespread adoption of pulse oximeters in developed regions results in high penetration rates. Many of the population, including healthcare facilities and individuals, may already possess these devices, reducing the potential for additional sales. For example, expanding beyond respiratory health monitoring to sports and fitness applications or integrating pulse oximeters into wearable devices may attract new user segments. These aspects can restrain the growth of the market.
End User Outlook
Based on end user, the market is segmented into hospitals & clinics, homecare, and others. In 2022, the homecare segment garnered a significant revenue share in the market. A more extensive movement has emerged towards healthcare provided at home, motivated by factors such as patient convenience, financial efficiency, and the capacity to oversee chronic ailments in a familiar environment. Pulse oximeters offer a practical and non-intrusive method for monitoring oxygen levels in one's residence. The worldwide population is aging, leading to an increased incidence of chronic respiratory conditions and various other health complications. Older people, in particular, may benefit from monitoring their oxygen saturation levels at home, leading to increased adoption of pulse oximeters in this demographic. Therefore, the segment will expand rapidly in the coming years.
Type Outlook
On the basis of type, the market is divided into handheld, fingertip, wrist worn, bedside, and others. In 2022, the fingertip segment witnessed the maximum revenue share in the market. The growth of remote patient monitoring practices, especially during the pandemic, contributed to the popularity of fingertip pulse oximeters. Patients could easily use these devices at home, with the data transmitted to healthcare providers for remote monitoring and intervention. These aspects will lead to increased demand in the segment.
Regional Outlook
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America, particularly the United States, has one of the highest healthcare spending levels globally. The well-established healthcare infrastructure and significant investments in medical technology contribute to the adoption of advanced medical devices like pulse oximeters. These aspects will pose lucrative growth prospects for the segment.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hill-Rom Holdings, Inc. (Welch Allyn) (Baxter International, Inc.), GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Nonin Medical, Inc., ICU Medical, Inc. (Smiths Medical), Medtronic PLC, OSI Systems, Inc. (Spacelabs Healthcare), Nihon Kohden Corporation, Meditech Equipment Co.,Ltd (Meditech Group), and Honeywell International, Inc.
Market Segments covered in the Report:
By End User (Volume, Thousand Units, USD billion, 2019-2030)
By Type (Volume, Thousand Units, USD billion, 2019-2030)
By Geography (Volume, Thousand Units, USD billion, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research